Sysmex ADR Research and Development Expenses 2016-2024 | SSMXY

Sysmex ADR research and development expenses for the twelve months ending December 31, 2024 were $0.152B, a 15.28% decline year-over-year.

  • Sysmex ADR annual research and development expenses for 2025 were $0.208B, a 0.17% decline from 2024.
  • Sysmex ADR annual research and development expenses for 2024 were $0.208B, a 9.52% decline from 2023.
  • Sysmex ADR annual research and development expenses for 2023 were $0.23B, a 3.58% decline from 2022.

Sysmex ADR Research and Development Expenses 2016-2024 | SSMXY

  • Sysmex ADR annual research and development expenses for 2025 were $0.208B, a 0.17% decline from 2024.
  • Sysmex ADR annual research and development expenses for 2024 were $0.208B, a 9.52% decline from 2023.
  • Sysmex ADR annual research and development expenses for 2023 were $0.23B, a 3.58% decline from 2022.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$183.5B
Thermo Fisher Scientific (TMO)$164.2B
Edwards Lifesciences (EW)$45.8B
Alcon (ALC)$43.1B
IDEXX Laboratories (IDXX)$42.9B
DexCom (DXCM)$32.7B
IQVIA Holdings (IQV)$28.2B
Mettler-Toledo (MTD)$25.4B
STERIS (STE)$22.4B
Waters (WAT)$21B
SONOVA HOLDING (SONVY)$17.4B
Hologic (HOLX)$14.6B
Penumbra (PEN)$9.2B
Masimo (MASI)$8.8B
Globus Medical (GMED)$7.7B
Glaukos (GKOS)$5.9B
Teleflex (TFX)$5.1B
Integer Holdings (ITGR)$4.2B
TransMedics (TMDX)$3.8B
PROCEPT BioRobotics (PRCT)$3.1B
LivaNova (LIVN)$2.4B
Veracyte (VCYT)$2.1B
Nihon Kohden (NHNKY)$1.9B
Elekta AB (EKTAY)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Paragon 28 (FNA)$1.1B
Pulse Biosciences (PLSE)$1.1B
OPKO Health (OPK)$1.1B
Tandem Diabetes Care (TNDM)$1B